the severity of neuropathy and reflects the movement disorders in these patients.
"Diabetic neuropathy and the duration of the relevant, and some patients can lead to muscle weakness and leg muscle atrophy," Anderson, University Hospital
Aarhus, Denmark (Henning Andersen) and his colleagues in October, "Journal of Diabetes Care" (Diabetes Care 2004; 27:2382-2385) wrote. The team has inspected
the foot in patients with diabetic neuropathy, whether within the muscle atrophy, and measurements can be used to indicate whether the extent of atrophy and
nerve lesions related to the process of movement disorders.
A total of 23 included a long-term diabetic patients - a (n = 15) or without (n = 8) chronic neuropathy - and 23 controls. The researchers received a
continuous foot muscle cross-sectional MRI image data in order to assess the total volume of muscles within the foot (VFM), the extent of neuropathy by a
basis of clinical examination, nerve conduction studies and quantitative sensory testing to determine the rank and points to evaluate.
Neuropathy in patients with a total VFM for the 86cm, non-neurological disease patients and healthy subjects were 165cm and 168cm. Neuropathy rank and sub-
inverse correlation with the VFM, but it has nothing to do with the duration of diabetes.
"Based on the clinical, electrophysiological and quantitative sensory testing, shrinking the extent and degree of neuropathy is closely related to that
support for our muscle atrophy within a foot can be well reflected in diabetic neuropathy dyskinesia assumptions."
